Shaolin Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Shaolin Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-525,001	Closed	-$29K	–	585
2023 Q3	$29K	Buy	525,001 +25,756	+5%	+$3.08K	﹤0.01%	368
2023 Q2	$74K	Buy	499,245 +99,300	+25%	+$10.3K	﹤0.01%	341
2023 Q1	$38K	Buy	399,945 +50,817	+15%	+$4.09K	﹤0.01%	470
2022 Q4	$35K	Hold	349,128	–	–	﹤0.01%	518
2022 Q3	$28K	Hold	349,128	–	–	﹤0.01%	668
2022 Q2	$49K	Buy	349,128 +124,128	+55%	+$23.2K	﹤0.01%	698
2022 Q1	$52K	Buy	+225,000	New	+$58.4K	﹤0.01%	767

Shaolin Capital Management's BIOSW Position: Q4 2023 in Review

Shaolin Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 525,001 shares — an estimated $29K sold.

Shaolin Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $74K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Shaolin Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Shaolin Capital Management sold 525,001 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $29K.
Shaolin Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Shaolin Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $74K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Shaolin Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.